CAAIF / Aralez Pharmaceuticals Canada Inc. Research Grant in Allergic Rhinitis - LOI

ABOUT CAAIF
The Canadian Asthma, Allergy and Immunology Foundation (CAAIF) is a charitable foundation whose mission is to invest in research leading to new and better treatments that improve the lives of Canadians living with allergy, asthma and immunologic diseases.

ABOUT ARALEZ PHARMACEUTICALS CANADA INC.
Aralez Pharmaceuticals Canada Inc. is a leading Canadian specialty pharmaceutical company with a primary focus on the acquisition, licensing, development and promotion of healthcare products primarily in allergy, dermatology and other specialty areas.

GRANT OBJECTIVE
The objective of the CAAIF/Aralez Pharmaceuticals Canada Inc. Research Grant in Allergic Rhinitis is to fund a research grant focused on the area of allergic rhinitis. 

VALUE OF THE AWARD
The maximum value of the award is $25,000.

ELIGIBILITY

  • The research must take place in Canada.
  • The proposal must be completed within a 12-month period.
  • Preference will be given to investigators who have not received this award within the past two years.
Contact Name: 
Penny D'Agnone
Grant Amount: 
$25,000
Grant Location: 
External
External Deadline: 
Thursday, September 24, 2020
Internal Deadline: 
Thursday, September 17, 2020
Grant Type: 
Awards
Grant Area: 
Health
Natural Science
Other
Grant Eligibility: 
Faculty
Postdoc
Other